Legend Biotech (LEGN) Announces Proposed $300M Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. AMAT
5. META
6. NRIX
7. SPY
8. SUNS
9. NVDA
10. CRDO

Go back to Legend Biotech (LEGN) Announces Proposed $300M Share Offering

Legend Biotech Corporation Announces Proposed Public Offering

December 14, 2021 4:28 PM EST

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it intends to offer and sell $300.0 million of American Depositary Shares (ADSs), each representing two ordinary shares, in an underwritten public offering. All ADSs to be sold in the proposed offering will be offered by Legend Biotech. Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of ADSs... More